Skip to main content

Table 3 Other NMS scales

From: The impact of clinical scales in Parkinson’s disease: a systematic review

S. no. NMS problems Different scales of NMS Features
1 Monitoring for NMS NMS-Q There are 30 items in all
Self-sufficient and a yes/no answer
NMS-S Physician administered 9 domains and having 30 items
Needs rating of frequency (1–4)/severity responses (0–3)
2 Quality of Life PDQ-39 Assess 39 item
Clinical administrated and covered by questionnaire
3 Autonomic dysfunction SCOPA Includes 25 items
No cut-off value is defined
4 Cognitive dysfunction PD-CRS Getting 7 activities that are administered by a clinician
Checking for memory issues
SCOPA:CS Having 10 tasks, clinician-administered
MoCA To detect mild cognitive impairment and PD dementia
5 Depression Ham-D Multiple versions of scale exist, but commonly version of 17 items is mostly used
Self-administered, clinician-administered, and semi-structured forms are all available
BDI Employs 21 items, self-completed, multiple choice answers
MADRS Consists of 10 items, clinician-administered
Not usually used
GDS Anxiety screening service for senior citizens, self-report, yes or no screening instrument
6 Anxiety STAI Diagnosing anxiety and differentiating it from depressive disorders
7 Sleep PDSS Having 15 items, self-completed
SCOPA: SS Identifying and evaluating the degree of daytime sleepiness
Uses self-completed 12 items
Looks at signs from the preceding month as well
PSQI Consists of 19 items, self-completed with monitoring of previous month symptoms
ESS A self-completed 8-item questionnaire with 0–3 rating on each item was used to determine the degree of daytime sleepiness
For pathologic sleepiness, a cut-off of 10/11 is used
ISCS Consists of 6 items, clinician-administered
SSS Calculating magnitude at a certain point in time
8 Apathy AES Based on an 18-item Likert scale
4 items scored solely by the patient, 1 item scored solely by the rater
AS Abridged AES, which was developed for PD and has a 4-point Likert scale of 14 items, was used in treatment trials
Patient's score (items are read to patient)
LARS In therapy trials, 33 items are used to screen for apathy
Structured interview with yes/no
9 Anhedonia SHPS Followed by 14 items, self-completed
10 Smell AHRS Ability to smell by asking questions
UPSI To quantify the olfactory function
11 Fatigue FSS After reading each phrase, the applicant must circle or round a number between 1 and 7
Self-administered, 9-item
A low value implies that the argument is not entirely true, while a high value indicates that it is
12 Pain DN4 Interview problems and physical measurements are used
A score of > 4 was deemed positive on the test
VAS To determine the severity of the pain
It varies from 0 (no pain) to 10 (extreme pain)
  1. NMS-Q NMS Questionnaire, NMS-S NMS scale, PDQ-39 PD questionnaire, SCOPA Scales for Outcomes in PD, PD-CRS PD Cognitive Rating Scale, SCOPA-CS SCOPA-Cognitive subscale, MoCA Montreal Cognitive Assessment, Ham-D Hamilton Depression Index, BDI Beck Depression Inventory, MADRS Montgomery–Asberg Depression Rating Scale, GDS Geriatric Depression Scale, STAI State–Trait Anxiety Inventory, PDSS PD Sleep Scale, SCOPA-SS Scales for Outcomes in PD- sleep subscale, PSQI Pittsburgh Sleep Quality Index, ESS Epworth Sleepiness Scale, ISCS Inappropriate Sleep Composite Score, SSS Stanford Sleepiness Scale, AES Apathy Evaluation Scale, AS Apathy Scale, LARS Lille Apathy Rating Scale, SHPS Snaith–Hamilton Pleasure Scale, AHRS Argentina Hyposmia Rating Scale, UPSIT University of Pennsylvania smell identification test, FSS Fatigue Severity Scale, DN4 Douleur Neuropathique-4 Questionnaire, VAS visual analogue scale